bluebird bio Inc to Separate Oncology Business into Independent Company Conference Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the bluebird bio conference call. (Operator Instructions) Please be advised that today's call may be recorded. (Operator Instructions)
I would now like to hand the call over to Ingrid Goldberg, Vice President of Investor Relations. Please go ahead.
Good morning, and thank you for joining today's bluebird bio 2021 JPMorgan Conference Call. Before we begin, I would like to remind everyone that we'll make statements about the company's future plans and prospects that constitute forward-looking statements. Actual results may differ materially as a result of various important factors, including those discussed in the company's SEC filings. These forward-looking statements represent our estimates as of today and should not be relied upon as representing our estimates as of any future date. We specifically disclaim any obligation to update forward-looking statements, even if our estimates change. Thank you for joining.
And I will now turn
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
